• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

microRNA-200a 通过靶向 CD47 促进巨噬细胞吞噬作用并抑制鼻咽癌细胞增殖、迁移和侵袭

MicroRNA-200a Promotes Phagocytosis of Macrophages and Suppresses Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma by Targeting CD47.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Department of Otolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, China.

出版信息

Biomed Res Int. 2020 Feb 20;2020:3723781. doi: 10.1155/2020/3723781. eCollection 2020.

DOI:10.1155/2020/3723781
PMID:32149101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7054800/
Abstract

Nasopharyngeal carcinoma (NPC) causes severe oncogenic lesions in the nasopharynx. CD47, a transmembrane integrin-associated protein, plays a key role in the ability of tumor cells to escape phagocytosis, working as an immune checkpoint in the immune response. Besides this role, CD47 has been reported to regulate cell proliferation and migration. The present study addresses the relationship between CD47 and microRNA-200a and examines their regulatory mechanisms in NPC. Bioinformatics analyses and dual-luciferase reporter assays were used to confirm the putative relationship between miR-200a and CD47, and their interaction was further detected using western blotting and RT-PCR. Further, results showed that miR-200a affect NPC cell proliferation, migration, and invasion by regulating CD47. A cell phagocytosis assay showed that miR-200a and a CD47 monoclonal antibody increased the sensitivity of NPC cells to macrophage phagocytosis by inhibiting the functions of CD47. Additionally, miR-200a expression was suppressed and CD47 expression increased in both clinical NPC tissues and cell lines. Taken together, these results show the miR-200a/CD47 combination as a potential therapeutic for treatment of NPC.

摘要

鼻咽癌(NPC)可导致鼻咽部严重的致癌病变。CD47 是一种跨膜整合素相关蛋白,在肿瘤细胞逃避吞噬作用的能力中发挥关键作用,作为免疫反应中的免疫检查点。除了这种作用外,CD47 还被报道可调节细胞增殖和迁移。本研究探讨了 CD47 与 microRNA-200a 之间的关系,并研究了它们在 NPC 中的调节机制。生物信息学分析和双荧光素酶报告基因实验用于证实 miR-200a 与 CD47 之间的假定关系,并通过 Western blot 和 RT-PCR 进一步检测它们的相互作用。进一步的结果表明,miR-200a 通过调节 CD47 影响 NPC 细胞的增殖、迁移和侵袭。细胞吞噬实验表明,miR-200a 和 CD47 单克隆抗体通过抑制 CD47 的功能增加 NPC 细胞对巨噬细胞吞噬的敏感性。此外,miR-200a 的表达在临床 NPC 组织和细胞系中受到抑制,而 CD47 的表达增加。总之,这些结果表明 miR-200a/CD47 组合可能成为 NPC 治疗的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6242/7054800/c77dfbd85e12/BMRI2020-3723781.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6242/7054800/806ef4efeb42/BMRI2020-3723781.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6242/7054800/7afa70025e32/BMRI2020-3723781.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6242/7054800/cd93fe0c23ee/BMRI2020-3723781.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6242/7054800/8950796c3e14/BMRI2020-3723781.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6242/7054800/c77dfbd85e12/BMRI2020-3723781.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6242/7054800/806ef4efeb42/BMRI2020-3723781.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6242/7054800/7afa70025e32/BMRI2020-3723781.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6242/7054800/cd93fe0c23ee/BMRI2020-3723781.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6242/7054800/8950796c3e14/BMRI2020-3723781.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6242/7054800/c77dfbd85e12/BMRI2020-3723781.005.jpg

相似文献

1
MicroRNA-200a Promotes Phagocytosis of Macrophages and Suppresses Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma by Targeting CD47.microRNA-200a 通过靶向 CD47 促进巨噬细胞吞噬作用并抑制鼻咽癌细胞增殖、迁移和侵袭
Biomed Res Int. 2020 Feb 20;2020:3723781. doi: 10.1155/2020/3723781. eCollection 2020.
2
Restoration of miR-340 controls pancreatic cancer cell expression to promote macrophage phagocytosis and enhance antitumor immunity.miR-340 的恢复可控制胰腺癌细胞的表达,促进巨噬细胞吞噬作用,并增强抗肿瘤免疫。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2019-000253.
3
Restoration of miR-299-3p promotes macrophage phagocytosis and suppresses malignant phenotypes in breast cancer carcinogenesis via dual-targeting CD47 and ABCE1.miR-299-3p 的恢复通过双重靶向 CD47 和 ABCE1 促进乳腺癌发生过程中巨噬细胞的吞噬作用并抑制恶性表型。
Int Immunopharmacol. 2024 Mar 30;130:111708. doi: 10.1016/j.intimp.2024.111708. Epub 2024 Feb 22.
4
MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.微小 RNA-629 通过靶向 PDCD4 促进鼻咽癌的增殖、侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):207-216. doi: 10.26355/eurrev_201901_16766.
5
MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.微小 RNA-449b-5p 通过靶向鼻咽癌中的 TPD52 抑制细胞增殖、迁移和侵袭。
J Biochem. 2019 Nov 1;166(5):433-440. doi: 10.1093/jb/mvz057.
6
miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion.miR-200a 通过下调 ZEB2 和 CTNNB1 水平,差异抑制鼻咽癌细胞的生长、迁移和侵袭。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):535-41. doi: 10.1016/j.bbrc.2009.11.093. Epub 2009 Nov 24.
7
MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.miR-203a-3p 通过抑制鼻咽癌中的 LASP1 来抑制细胞增殖和转移。
J Exp Clin Cancer Res. 2017 Oct 5;36(1):138. doi: 10.1186/s13046-017-0604-3.
8
EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells.EBV-EBNA1 通过促进 Treg 细胞的趋化吸引作用,为鼻咽癌构建免疫抑制微环境。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001588.
9
MicroRNA-200a mediates nasopharyngeal carcinoma cell proliferation through the activation of nuclear factor-κB.微小RNA-200a通过激活核因子-κB介导鼻咽癌细胞增殖。
Mol Med Rep. 2016 Feb;13(2):1732-8. doi: 10.3892/mmr.2015.4738. Epub 2015 Dec 30.
10
Hydrogen gas represses the progression of lung cancer via down-regulating CD47.氢气通过下调 CD47 抑制肺癌进展。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20192761.

引用本文的文献

1
Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment.针对CD47-SIRPα信号通路的治疗策略在胃肠道癌症治疗中的应用
J Pharm Anal. 2025 Jan;15(1):101099. doi: 10.1016/j.jpha.2024.101099. Epub 2024 Sep 12.
2
Deciphering the role of CD47 in cancer immunotherapy.解析 CD47 在癌症免疫疗法中的作用。
J Adv Res. 2024 Sep;63:129-158. doi: 10.1016/j.jare.2023.10.009. Epub 2023 Oct 28.
3
m6A-methylated KCTD21-AS1 regulates macrophage phagocytosis through CD47 and cell autophagy through TIPR.

本文引用的文献

1
Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis.通过阻断 CD47/SIRPɑ 轴工程化巨噬细胞吞噬癌细胞。
Cancer Med. 2019 Aug;8(9):4245-4253. doi: 10.1002/cam4.2332. Epub 2019 Jun 11.
2
PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma.PD-1 高表达预示 IV 期 M0 鼻咽癌局部疾病控制率较低。
BMC Cancer. 2019 May 28;19(1):503. doi: 10.1186/s12885-019-5689-y.
3
The role of the miR-200 family in epithelial-mesenchymal transition in colorectal cancer: a systematic review.
m6A 甲基化 KCTD21-AS1 通过 CD47 和细胞自噬通过 TIPR 调节巨噬细胞吞噬作用。
Commun Biol. 2024 Feb 21;7(1):215. doi: 10.1038/s42003-024-05854-x.
4
The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation.免疫检查点在肿瘤中的增殖作用:双重调节
Cancers (Basel). 2022 Oct 31;14(21):5374. doi: 10.3390/cancers14215374.
5
NDR1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer.NDR1 通过增加 ASCL1 的蛋白稳定性和核定位来激活 CD47 的转录,从而增强小细胞肺癌中的癌症干细胞特性和逃避吞噬作用。
Med Oncol. 2022 Oct 12;39(12):254. doi: 10.1007/s12032-022-01859-w.
6
The role of miR-200 family in the regulation of hallmarks of cancer.miR-200家族在癌症特征调控中的作用。
Front Oncol. 2022 Sep 8;12:965231. doi: 10.3389/fonc.2022.965231. eCollection 2022.
7
Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?靶向髓系检查点分子联合抗体治疗:IgA 抗体的新型抗癌策略?
Front Immunol. 2022 Jul 5;13:932155. doi: 10.3389/fimmu.2022.932155. eCollection 2022.
8
MicroRNAs as Regulators of Phagocytosis.MicroRNAs 作为吞噬作用的调节因子。
Cells. 2022 Apr 19;11(9):1380. doi: 10.3390/cells11091380.
9
The Role of NcRNAs to Regulate Immune Checkpoints in Cancer.非编码 RNA 调控癌症免疫检查点的作用。
Front Immunol. 2022 Apr 6;13:853480. doi: 10.3389/fimmu.2022.853480. eCollection 2022.
10
Targeting CD47/SIRPα as a therapeutic strategy, where we are and where we are headed.将CD47/SIRPα作为一种治疗策略的靶向研究,我们目前的进展及未来的方向。
Biomark Res. 2022 Apr 13;10(1):20. doi: 10.1186/s40364-022-00373-5.
miR-200 家族在结直肠癌上皮间质转化中的作用:系统评价。
Int J Cancer. 2018 Jun 15;142(12):2501-2511. doi: 10.1002/ijc.31282. Epub 2018 Feb 21.
4
MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47.MIR-708 通过靶向 CD47 促进吞噬作用以清除 T-ALL 细胞。
Mol Cancer. 2018 Jan 24;17(1):12. doi: 10.1186/s12943-018-0768-2.
5
SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy.SIRPα-CD47 免疫检查点阻断在癌症治疗中的应用。
Trends Immunol. 2018 Mar;39(3):173-184. doi: 10.1016/j.it.2017.12.005. Epub 2018 Jan 11.
6
Blocking the CD47-SIRPα axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells.通过递送抗CD47抗体阻断CD47-SIRPα轴可诱导对胶质瘤和胶质瘤干细胞的抗肿瘤作用。
Oncoimmunology. 2017 Nov 6;7(2):e1391973. doi: 10.1080/2162402X.2017.1391973. eCollection 2018.
7
Cancer immunotherapy targeting the CD47/SIRPα axis.靶向CD47/SIRPα轴的癌症免疫疗法。
Eur J Cancer. 2017 May;76:100-109. doi: 10.1016/j.ejca.2017.02.013. Epub 2017 Mar 10.
8
MiR-155-regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis.微小RNA-155调控的分子网络在针对结核分枝杆菌的固有免疫和适应性免疫反应中协调细胞命运。
Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6172-E6181. doi: 10.1073/pnas.1608255113. Epub 2016 Sep 28.
9
miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint.miR-424(322) 通过阻断 PD-L1 免疫检查点来激活 T 细胞免疫反应,从而逆转化疗耐药。
Nat Commun. 2016 May 5;7:11406. doi: 10.1038/ncomms11406.
10
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.肾细胞癌患者CD8⁺T细胞中miR-29b和miR-198的过表达下调JAK3和MCL-1,导致免疫功能障碍。
J Transl Med. 2016 Apr 11;14:84. doi: 10.1186/s12967-016-0841-9.